Improved quality-control detection of false-negative Pap smears using the AutoPap 300 QC system

Diagnostic Cytopathology

Volumn 20, Issue 3, 1999, Pages 170-174

  Marshall, C Jay ^a,b   Rowe, Leslie ^b   Bentz, Joel S ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

AutoPap 300 QC system; Cervical smears; Quality control

Indexed keywords

ARTICLE; AUTOMATION; HUMAN; LABORATORY DIAGNOSIS; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MASS SCREENING; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0033027316     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199903)20:3<170::AID-DC12>3.0.CO;2-6     Document Type: Article

References (34)

1. Cramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer 1974;34:2018-2027.
2. Christopherson WM, Lundin FE, Mendez WM, Parker JE. Cervical cancer control. A study of morbidity and mortality trends over a twenty-one year period. Cancer 1976;38:1357-1366.
3. Kitai K, Rigal RD, Patrick JR, et al. The changing trends of uterine cancer and cytology. Cancer 1978;42:2439-2449.
4. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987;329:1247-1249.
5. Anderson GH, Boyes DA, Benedet JL, et al. Organisation and results of the cervical cytology screening program in British Columbia, 1955-1985. Br Med J [Clin Res] 1988;296:975-978.
6. Parker S, Tong T, Bolden S, et al. Cancer statistics 1996. CA 1996;46:5-27.
7. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-192.
8. Peters RK, Thomas D, Skultin G, Henderson BE. Invasive squamous cell carcinoma of the cervix after recent negative cytologic test results. Am J Obstet Gynecol 1988;158:926-935.
9. Kristentsen GB, Skyggebjerg K, Holund B, et al. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. Acta Cytol 1991;35:47-50.
10. Anderson GH, Benedet JL, Le Riche JC, et al. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol 1992;80:1-4.
11. Wain GV, Farnsworth A, Hacker NF. The Papanicolaou smear histories of 237 patients with cervical cancer. Med J Aust 1992;157:14-16.
12. Janerich DT, Hadjimichael O, Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 1995;85:791-794.
13. Fetherston WC. False negative cytology in invasive cancer of the cervix. Clin Obstet Gynecol 1983;26:929-937.
14. Walker EM, Hare MJ, Cooper P. A retrospective review of cervical cytology in women developing invasive squamous cell carcinoma. Br J Obstet Gynaecol 1983;90:1087-1091.
15. Carmichael JA, Jeffrey JF, Steele HD, Ohlke ID. The cytology history of 245 patients developing invasive cervical carcinoma. Am J Obstet Gynecol 1984;148:685-690.
16. Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol 1985;29:1043-1046.
17. Roberts AW, Lane DA, Buntine D, Wright RG. Invasive carcinoma of the cervix in young women. Med J Aust 1985;143:333-335.
18. Sfameni SF, Jobling TW, Trickey NRA, Havelock C. Evaluation of serial cervical cytology in the assessment of preinvasive cervical neoplasia. Aust N Z J Obstet Gynaecol 1989;29:40-43.
19. Jones BA, Novis DA. Cervical biopsy cytology correlation: data analysis and critique. 94-09. Q-probes. Northfield, IL: College of American Pathologists, 1994.
20. Department of Health and Human Services. 42 CFR part 405 Clinical Laboratory Improvement Amendments of 1988. Final rule. Fed Reg 1992;57:7001-7288.
21. Melamed MR, Flehinger BJ. Reevaluation of quality assurance in the cytology laboratory. Acta Cytol 1992;36:461-465.
22. Baker A, Melcher DH. Rapid cervical cytology screening. Cytopathology 1991;2:299-201.
23. Faraker CA. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening. Cytopathology 1993;4:47-50.
24. Dudding N. Rapid rescreening of cervical smears: an improved method of quality control. Cytopathology 1995;6:95-99.
25. Baker A, Melcher D, Smith R. Role of rescreening of cervical smears in internal quality control. J Clin Pathol 1995;48:1002-1004.
26. Faraker CA. Partial rescreening as a quality assurance method. Acta Cytol 1996;40:1323.
27. Farrell DJ, Bilkhu S, Gibson LM, et al. Rapid screening of cervical smears as a method of internal quality control. For how long should we rescreen? Acta Cytol 1997;41:251-260.
28. Colgan TJ, Patten SF, Lee JSJ. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory. Acta Cytol 1995;39:1191-1198.
29. Patten SF, Lee JSJ, Nelson AC. NeoPath AutoPap 300 automatic Pap screener system. Acta Cytol 1996;40:45-52.
30. Wilbur DC, Bonfiglio TA, Rutkowski MA, et al. Sensitivity of the AutoPap 300 QC system for cervical cytologic abnormalities. Acta Cytol 1996;40:127-132.
31. Lee JSJ, Wilhelm P, Kuan L, et al. AutoPap system performance in screening for low prevalence and small cell abnormalities. Acta Cytol 1997;41:56-64.
32. Husain OAN, Butler EB, Evans DMD, et al. Quality control in cervical cytology. J Clin Pathol 1974;27:935-994.
33. Rubio CA. False negatives in cervical cytology: can they be avoided? Acta Cytol 1981;25:199-202.
34. Keebler C. A quality assurance program for the cytology laboratory. In: Wied GL, Keebler CM, Rosenthal DL, Schenck U, Somrak TM, Vooijs GP, editors. Compendium on quality assurance, proficiency testing and workload limitations in clinical cytology. Chicago: Tutorials of Cytology; 1995. p 207-221.